by Igen BioLab Group | Dec 18, 2020 | News, Publications
Although intestinal microbiome have been established as an important biomarker and regulator of cancer development and therapeutic response, less is known about the role of microbiome at other body sites in cancer. Emerging evidence has revealed that the local...
by Igen BioLab Group | Dec 15, 2020 | News, Publications
The correlations between microbiota dysbiosis and cancer have gained extensive attention and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a great threat to human health. The healthy human lungs are consistently exposed to external...
by Igen BioLab Group | Nov 19, 2020 | News, Publications
Several species of intestinal bacteria have been associated with enhanced efficacy of checkpoint blockade immunotherapy, but the underlying mechanisms by which the microbiome enhances antitumor immunity are unclear. bacteria Several species of intestinal bacteria have...
by Igen BioLab Group | Nov 13, 2020 | News, Publications
The human microbiome comprising microorganisms, their collective genomes and metabolic products has gained tremendous research interest in oncology, as multiple cohorts and case studies have demonstrated discernible interpatient differences in this ecosystem based on...
by Igen BioLab Group | Oct 13, 2020 | Events
The 14th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2020 will now be held 11 November 2020. This full day live stream keynote sessions will be recorded and available for all participants after the Conference. In...
